SmartQR Technologies Pvt Ltd

Call Website Contact the business

SmartQR Technologies Pvt Ltd Specializes in developing innovative and cutting-edge healthcare solutions to enhance public health.

May Lord Ganesha bless us with wisdom, prosperity, good health, and the courage to embrace new beginnings. ✨Wishing you ...
14/09/2026

May Lord Ganesha bless us with wisdom, prosperity, good health, and the courage to embrace new beginnings. ✨

Wishing you and your loved ones a blessed and joyful Ganesh Chaturthi!

SmartQR is proud to have associated with IIT Kharagpur, -IIT , DSIR for the Event.Hon Secretary DSIR & DG CSIR Dr N Kala...
07/09/2026

SmartQR is proud to have associated with IIT Kharagpur, -IIT , DSIR for the Event.

Hon Secretary DSIR & DG CSIR Dr N Kalaiselvi Mam, Director IIT Kharagpur Dr Suman Chakraborty Sir & Many Other distinguished guests shared their thoughts.

We were proud to show case our products, future plan as one of the very few companies in India working on holistic, people friendly & need of the hour solutions in MedTech in Genomics, Molecular Biology & Other IVD Devices.

đź”— Watch the full event: https://www.youtube.com/live/pjUspxav_YA?si=9QRH7wCmWoUfuo_V

Precision medicine begins with precision data.InGene is SmartQR's advanced genomics platform designed to support molecul...
31/08/2026

Precision medicine begins with precision data.

InGene is SmartQR's advanced genomics platform designed to support molecular analysis and help clinicians gain deeper biological insights for informed clinical decisions.

By bringing genomics closer to everyday healthcare, InGene supports the transition from conventional diagnostics to precision-driven medicine.

Because better decisions begin with better understanding.

The genomics conversation in India has shifted in the last two years — from “should we adopt this” to “how fast can we s...
20/08/2026

The genomics conversation in India has shifted in the last two years — from “should we adopt this” to “how fast can we scale it.”

India's precision medicine market is growing at a projected 16% CAGR through 2030, with diagnostics leading that growth, and government-backed initiatives are accelerating what used to be a slow adoption curve.

But market growth alone doesn't solve the real industry challenge: most of this capability still sits in a handful of metro hospitals.

The next phase for genomics in India isn't about proving the science — it's about building the infrastructure to make it accessible at scale.

We did it.After months of hard work, thousands of conversations, and unwavering belief in the power of accessible diagno...
17/08/2026

We did it.

After months of hard work, thousands of conversations, and unwavering belief in the power of accessible diagnostics—SmartQR just secured a $1M order for our PrePapQR Test Kit.

1.5 MILLION kits.
1.5 MILLION women with answers.

This is what women's health innovation looks like at scale.

Celebrating the freedom to think, innovate and build a healthier tomorrow. 🇮🇳This Independence Day, SmartQR celebrates I...
15/08/2026

Celebrating the freedom to think, innovate and build a healthier tomorrow. 🇮🇳

This Independence Day, SmartQR celebrates India’s spirit of progress and the power of innovation to transform healthcare for every Indian.

Wishing everyone a Happy Independence Day! 🇮🇳

Genomics is often associated with DNA sequencing. But its true value lies beyond reading genetic information.It helps us...
05/08/2026

Genomics is often associated with DNA sequencing. But its true value lies beyond reading genetic information.
It helps us understand why diseases develop differently, why treatments work differently for different people, and how healthcare can become increasingly personalized.

As medicine evolves, genomics is shifting clinical decision-making from generalized treatment to biology-driven care.

Because the future of healthcare is not simply about treating disease—it is about understanding the individual.

GLP drugs are increasingly being prescribed across India for metabolic conditions. But here is a question that does not ...
15/07/2026

GLP drugs are increasingly being prescribed across India for metabolic conditions.

But here is a question that does not get asked often enough: Will this drug actually work for the patient?
The answer depends, in large part, on their DNA.

Every patient's body processes GLP medication differently.

Genetic variations influence how quickly the drug is metabolised, how effectively it acts and what side effects a patient is likely to experience.

Prescribing without this information means relying on trial and error and in metabolic care, that can cost patients weeks or months of ineffective treatment.

SmartGLP changes that.

It is a DNA-based test designed to help doctors understand a patient's likely response to GLP treatment before the prescription is written.

By analysing the key genes that influence GLP drug metabolism, SmartGLP enables doctors to select the right drug, at the right dose, for the right patient from day 1.

Because in precision medicine, the goal is to treat right.

HPV is one of the most common infections linked to cervical cancer. But research increasingly shows that infection alone...
25/05/2026

HPV is one of the most common infections linked to cervical cancer. But research increasingly shows that infection alone does not determine risk.
Genetics also plays a role.

Studies suggest that genetic differences can influence how the body responds to HPV, including immune response, persistence of infection and progression to cervical abnormalities.
This is why 2 individuals with similar HPV exposure may experience very different outcomes.

As women’s healthcare moves toward more preventive and personalized care, molecular and genetic insights are becoming increasingly important in supporting proactive clinical decisions.

Understanding risk earlier can lead to better monitoring, earlier action and more informed care.

GLP drugs are becoming one of the most prescribed treatments for metabolic conditions in India. And for good reason.Indi...
18/05/2026

GLP drugs are becoming one of the most prescribed treatments for metabolic conditions in India.
And for good reason.

India carries one of the highest numbers of diabetes, obesity and cardiovascular disease cases in the world and GLP-based therapies offer real promise.

But there is a gap that does not get talked about enough.
Not every patient responds to GLP treatment the same way.

Genetic variation means the same drug, at the same dose, can produce very different outcomes from one patient to the next.

Yet most prescriptions are still written without this information.

The tools to change this already exist. Pharmacogenomic testing can tell us, before treatment begins, how a patient's body is likely to respond to a specific drug.

The next step for metabolic care in India is moving from standardised prescribing to precision prescribing, where treatment decisions are guided by the patient's own biology.

That is the gap SmartQR is working to close.

Address

Sr No 213, Rishi House, Plot 65, Hindustan Estate, Kalyaninagar
Pune
411006

Opening Hours

Monday 9am - 7pm
Tuesday 9am - 7pm
Wednesday 9am - 7pm
Thursday 9am - 7pm
Friday 9am - 7pm
Saturday 9am - 7pm

Telephone

+918956276294

Website

Alerts

Be the first to know and let us send you an email when SmartQR Technologies Pvt Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to SmartQR Technologies Pvt Ltd:

Shortcuts

Share

Category